Ivermectin for prostate cancer

Ivermectin inhibits AR pathway in prostate cancer models.

Resistance to AR pathway inhibitors in prostate cancer is associated with AR amplification, mutations, and expression of truncated AR variants, the latter characterized by loss of AR’s ligand-binding domain and constitutively active transcription (24).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994194/#:~:text=Ivermectin%20inhibits%20AR%20pathway%20in,constitutively%20active%20transcription%20(24).

I love the hypocrisy of this. Three years you guys have been clowning on "trust the science" but the SECOND it says something you want to hear you eat it up like you're raccoons trapped in a dumpster on a hot summer day.

Absolute 🤡 show in here sometimes.

Oh and the “trust the science” line - that’s a sleeping sheep mantra. You must have confused AU for Twitter.

You may feel as you do, but delivery is everything.

You seem to be replying to the wrong message.